---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-009069"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:07:13.393465+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ZIVO Bioscience appoints Laith Yaldoo to board, expands to 5 members

## Summary
- Board increased from 4 to 5 members; Laith Yaldoo appointed effective July 11, 2024.
- Yaldoo is managing member of HEP Investments LLC; background in biotech, healthcare, and card processing.
- He will stand for election as a Class I director at the 2026 annual meeting.
- No family relationships or related party transactions with current officers/directors.
- Yaldoo will participate in the Company’s standard outside director compensation program.

## SEC filing metadata
- accession: 0001654954-24-009069
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495424009069/0001654954-24-009069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495424009069/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-009069
- JSON: https://secwatch.observer/filing/0001654954-24-009069.json
- Plain text: https://secwatch.observer/filing/0001654954-24-009069.txt

## Key facts
- Executive change
  Laith Yaldoo was appointed as Director at Zivo Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 11, 2024, the Board of Directors of ZIVO Bioscience Inc., (the “Company”) increased its size from four (4) to five (5) members and appointed Laith Yaldoo to fill the vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495424009069/0001654954-24-009069-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.